Estrella Immunopharma, Inc. Common Stock
Symbol: ESLA (NASDAQ)
1.04
▼ (-1.43%) -0.015
Company Description:
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
Key Stats
- Today's Open: $1.032
- Today's High: $1.037
- Today's Low: $1.032
- Today's Volume: 211
- Yesterday Close: $1.05
- Yesterday High: $1.08
- Yesterday Low: $0.9901
- Yesterday Volume: 22.55K
- Last Min Volume: 200
- Last Min High: $1.035
- Last Min Low: $1.035
- Last Min VWAP: $1.035
Company Profile
- Name: Estrella Immunopharma, Inc. Common Stock
- Website: https://www.estrellabio.com
- Listed Date: 2023-10-02
- Location: EMERYVILLE, CA
- Market Status: Active
- CIK Number: 0001844417
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $38.92M
- Round Lot: 100
- Outstanding Shares: 37.07M
- Asset Type: CS
RECENT FILINGS FOR ESLA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-06-05 | 8-K | View |
| 2025-06-03 | 8-K | View |
| 2025-05-29 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-02 | 8-K | View |
| 2025-03-25 | 10-KT | View |
| 2025-02-21 | 8-K | View |
| 2025-02-20 | 8-K | View |
| 2025-02-14 | 4 | View |
| 2025-02-14 | 4 | View |
| 2024-12-23 | S-8 | View |
| 2024-12-19 | EFFECT | View |
| 2024-12-17 | CORRESP | View |
| 2024-12-17 | 424B3 | View |
| 2024-12-17 | UPLOAD | View |
| 2024-12-16 | 8-K | View |
| 2024-12-12 | S-3 | View |
| 2024-12-09 | 424B3 | View |
Latest News on ESLA